Unibest

UB341

TargetsTL1A; IL-23p19
IndicationsInflammatory bowel disease; Psoriasis
ClinicalCN - Pre-IND
TherapeuticsDermatology
ModalitiesAntibody

Asset Materials

UB341 Asset Materials

我们能如何帮助您?

获取最新活动与法规动态洞察

直接发送到您的邮箱

在此获取行业洞察与 Unibest 动态

联系我们 →